24 May 2013
Keywords: positive, ph, ii, results, versicor, anidulafungin, revealed
Article | 24 March 2003
Versicor has revealed positive results from a pivotal Phase IIIclinical trial with its lead product candidate, anidulafungin, an anti-fungal agent, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.